In this study, we demonstrate that SCAMP5 expression is reduced in β‐cells under diabetogenic situations, which is involved in hyperglycemia‐activated ChREBP‐mediated reduction of H3K4me3 at the Scamp5 promoter. This evidence concerns the gene MLXIPL and Hyperglycemia.